Page last updated: 2024-11-01

ofloxacin and Experimental Neoplasms

ofloxacin has been researched along with Experimental Neoplasms in 1 studies

Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kajimura, T1
Tojo, H1
Kudo, G1
Yamada, M1
Domon, S1
Nomura, M1
Takayama, S1

Other Studies

1 other study available for ofloxacin and Experimental Neoplasms

ArticleYear
Effect of the new quinolone antibacterial agent levofloxacin on multiple organ carcinogenesis initiated with wide-spectrum carcinogens in rats.
    Arzneimittel-Forschung, 1992, Volume: 43, Issue:3A

    Topics: Animals; Anti-Infective Agents; Body Weight; Carcinogens; Drinking; Eating; Levofloxacin; Male; Neop

1992